Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Sep;45(9):732–735. doi: 10.1136/ard.45.9.732

Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study.

A A Drosos, F N Skopouli, J S Costopoulos, C S Papadimitriou, H M Moutsopoulos
PMCID: PMC1001978  PMID: 3532967

Abstract

The efficacy and toxicity of cyclosporin A (CyA) were studied in a blind fashion in 20 patients with primary Sjögren's syndrome (pSS). The dose of CyA or placebo was 5 mg/kg of body weight daily. Among the 20 patients, 10 received CyA and 10 placebo. The two groups were matched for age, sex, and disease duration. Patients treated with CyA improved in subjective xerostomia in comparison with patients treated with placebo. Subjective xerophthalmia and recurrent parotid gland enlargement did not differ in the two groups. No change in Schirmer's test and stimulated parotid flow rate was observed in either group. In contrast, the histopathological lesion of patients treated with CyA remained unchanged in most of the patients, while in the placebo treated group the lesion deteriorated. Laboratory parameters did not change before or after treatment in either group. The only clinical side effect observed in the CyA treated group was hypertrichosis.

Full text

PDF
732

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrus L., Lafferty K. J. Inhibition of T-cell activity by cyclosporin A. Scand J Immunol. 1981 May;15(5):449–458. doi: 10.1111/j.1365-3083.1982.tb00670.x. [DOI] [PubMed] [Google Scholar]
  2. Bertram U. Xerostomia. Clinical aspects, pathology and pathogenesis. Acta Odontol Scand. 1967;25(Suppl):1–126. [PubMed] [Google Scholar]
  3. Borel J. F., Feurer C., Gubler H. U., Stähelin H. Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions. 1976 Jul;6(4):468–475. doi: 10.1007/BF01973261. [DOI] [PubMed] [Google Scholar]
  4. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  5. Graf U., Marbet U., Müller W., Thiel G. Cyclosporin A--Wirkungen und Nebenwirkungen bei der Behandlung der chronischen Polyarthritis und der Psoriasisarthritis. Immun Infekt. 1981 Mar;9(1):20–28. [PubMed] [Google Scholar]
  6. Howlett T. A., Lawton N. F., Fells P., Besser G. M. Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment. Lancet. 1984 Nov 10;2(8411):1101–1101. doi: 10.1016/s0140-6736(84)91541-1. [DOI] [PubMed] [Google Scholar]
  7. Isenberg D. A., Snaith M. L., Morrow W. J., Al-Khader A. A., Cohen S. L., Fisher C., Mowbray J. Cyclosporin A for the treatment of systemic lupus erythematosus. Int J Immunopharmacol. 1981;3(2):163–169. doi: 10.1016/0192-0561(81)90007-2. [DOI] [PubMed] [Google Scholar]
  8. Kassan S. S., Thomas T. L., Moutsopoulos H. M., Hoover R., Kimberly R. P., Budman D. R., Costa J., Decker J. L., Chused T. M. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978 Dec;89(6):888–892. doi: 10.7326/0003-4819-89-6-888. [DOI] [PubMed] [Google Scholar]
  9. Nussenblatt R. B., Palestine A. G., Chan C. C. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983 Sep;96(3):275–282. doi: 10.1016/s0002-9394(14)77814-6. [DOI] [PubMed] [Google Scholar]
  10. Nussenblatt R. B., Palestine A. G., Rook A. H., Scher I., Wacker W. B., Gery I. Treatment of intraocular inflammatory disease with cyclosporin A. Lancet. 1983 Jul 30;2(8344):235–238. doi: 10.1016/s0140-6736(83)90230-1. [DOI] [PubMed] [Google Scholar]
  11. Tarpley T. M., Jr, Anderson L. G., White C. L. Minor salivary gland involvement in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol. 1974 Jan;37(1):64–74. doi: 10.1016/0030-4220(74)90160-1. [DOI] [PubMed] [Google Scholar]
  12. Tumiati B., Bellelli A., Baricchi R., Portioli R. I. Cyclosporin for rheumatoid arthritis: one case. Clin Exp Rheumatol. 1985 Oct-Dec;3(4):361–362. [PubMed] [Google Scholar]
  13. Weetman A. P., McGregor A. M., Ludgate M., Beck L., Mills P. V., Lazarus J. H., Hall R. Cyclosporin improves Graves' ophthalmopathy. Lancet. 1983 Aug 27;2(8348):486–489. doi: 10.1016/s0140-6736(83)90514-7. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES